Rachel McMinn Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rachel McMinn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rachel McMinn. Rachel McMinn is Chief Strategy Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Rachel McMinn in INTERCEPT PHARMACEUTICALS, INC.
Trading Symbol: ICPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rachel McMinn: Chief Strategy Officer
Holdings: 16,875 shares
Current Value: $1,916,494
Latest Transaction: Oct 04 2017
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Rachel McMinn in INTERCEPT PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 04 2017 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 58.89 | 283 | 16,667 | 16,875 | 17.2 K to 16.9 K (-1.65 %) |
Aug 02 2017 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 123.12 | 130 | 16,005 | 17,158 | 17.3 K to 17.2 K (-0.75 %) |
Jul 05 2017 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 121.78 | 257 | 31,297 | 17,288 | 17.5 K to 17.3 K (-1.46 %) |
May 03 2017 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 113.12 | 114 | 12,896 | 17,545 | 17.7 K to 17.5 K (-0.65 %) |
Apr 05 2017 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 115.00 | 257 | 29,554 | 17,659 | 17.9 K to 17.7 K (-1.43 %) |
Feb 03 2017 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Option Exercise | A | 107.18 | 8,300 | 889,594 | 8,300 | |
Feb 03 2017 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Grant | A | 0.00 | 5,000 | 0 | 17,916 | 12.9 K to 17.9 K (+38.71 %) |
Jan 05 2017 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 103.92 | 816 | 84,798 | 12,916 | 13.7 K to 12.9 K (-5.94 %) |
Nov 02 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 123.82 | 129 | 15,972 | 13,732 | 13.9 K to 13.7 K (-0.93 %) |
Aug 02 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 176.57 | 125 | 22,071 | 13,861 | 14 K to 13.9 K (-0.89 %) |
Jul 07 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 145.11 | 106 | 15,382 | 13,986 | 14.1 K to 14 K (-0.75 %) |
May 04 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 147.49 | 130 | 19,174 | 14,087 | 14.2 K to 14.1 K (-0.91 %) |
Apr 06 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 130.76 | 104 | 13,599 | 14,217 | 14.3 K to 14.2 K (-0.73 %) |
Feb 12 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Option Exercise | A | 95.74 | 8,800 | 842,512 | 8,800 | |
Feb 12 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Grant | A | 0.00 | 6,700 | 0 | 14,321 | 7.6 K to 14.3 K (+87.91 %) |
Feb 03 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 103.56 | 128 | 13,256 | 7,621 | 7.7 K to 7.6 K (-1.65 %) |
Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 145.90 | 469 | 68,429 | 7,749 | 8.2 K to 7.7 K (-5.71 %) |
Nov 04 2015 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 160.24 | 125 | 20,029 | 8,218 | 8.3 K to 8.2 K (-1.50 %) |
Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Option Exercise | A | 161.16 | 10,600 | 1,708,296 | 10,600 | |
Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Grant | A | 0.00 | 4,050 | 0 | 8,343 | 4.3 K to 8.3 K (+94.34 %) |
Aug 04 2015 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 262.09 | 127 | 33,286 | 4,293 | 4.4 K to 4.3 K (-2.87 %) |
Jul 17 2015 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 255.12 | 503 | 128,327 | 4,420 | 4.9 K to 4.4 K (-10.22 %) |
May 02 2014 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Option Exercise | A | 264.12 | 6,467 | 1,708,064 | 6,467 | |
May 02 2014 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Option Exercise | A | 264.12 | 6,004 | 1,585,776 | 6,004 | |
May 02 2014 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Grant | A | 0.00 | 4,923 | 0 | 4,923 | 0 to 4.9 K |
Page: 1